1. Slovenija
  2. All 3M Products
  3. Medical
  4. Skin Care
  5. No-Sting Barrier Films
  6. 3M™ Cavilon™ No Sting Barrier Film

3M™ Cavilon™ No Sting Barrier Film

  • Options available
  • | Select product options for IDs.

Primary barrier against body fluids, for improved continence care that doesn’t require removal

Alcohol-free and non-stinging, comfortable to use even on sore, damaged skin

Safe; will not interfere with the healing process of sore, damaged skin³ ⁴

View more details

Details

Highlights
  • Primary barrier against body fluids, for improved continence care that doesn’t require removal
  • Alcohol-free and non-stinging, comfortable to use even on sore, damaged skin
  • Safe; will not interfere with the healing process of sore, damaged skin³ ⁴
  • Fast-drying and non-sticky, for ease of use and patient comfort⁵
  • Proven to help protect the skin during IV site care⁶. Chlorhexidine gluconate and povidone iodine compatible⁷
  • Peel-open pouch facilitates aseptic delivery technique (3343 only)
  • Allows adhesives to stick
  • A proven solution with over 80 pieces of evidence supporting its efficacy and cost savings⁸ ⁹

3M™ Cavilon™ No Sting Barrier Film is the original alcohol-free liquid barrier film that dries quickly to form a breathable, transparent coating on the skin.

It is designed to protect intact, damaged or 'at-risk' skin from urine, faeces, other body fluids, medical adhesive related skin injury (MARSI) and friction. It lasts for up to 72 hours¹ ² , and will not sting when applied to broken skin.

Suggested applications
  • Prevention of IAD (incontinence-associated dermatitis)⁸
  • Peristomal/Peritube skin protection⁸
  • Periwound skin protection⁸
  • Medical adhesive-related skin injury (MARSI) prevention around I.V. sites, under dressings, tapes and negative pressure wound therapy (NPWT)⁸
  • Protection from moisture and friction ¹⁰ (intertriginous dermatitis)

Specifications

Resources

Connect with us. We’re here to help.

Need help finding the right product for your project? Contact us if you need product, technical or application advice or want to collaborate with a 3M technical specialist

Pošljite nam sporočilo

Zahvaljujemo se vam za zanimanje za 3M. Da bomo na vaše vprašanje odgovorili v najkrajšem možnem času, vas vljudno prosimo, da navedete nekaj ključnih informacij, vključno z vašimi kontaktnimi podatki. Na osnovi posredovanih podatkov, bo na vaše vprašanje odgovoril po e-pošti ali telefonu predstavnik podjetja ali eden od naših pooblaščenih poslovnih partnerjev, s katerimi bomo morda delili vaše osebne podatke v skladu s politiko zasebnosti 3M.

  •  
  •  
  •  
  •  
  •  
  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Pošlji sporočilo

Zahvaljujemo se vam, da ste se obrnili na podjetje 3M

Prejeli smo vaše sporočilo in zdaj obravnavamo vašo poizvedbo
Naš predstavnik vas bo kontaktiral po telefonu ali e-pošti.

An error occurred.


¹ 2010 Grove et al. 3M White Paper. A Comparison of the Durability of Four Barrier Film Products Over a 72 Hour Period on Human Volunteers. ² CLIN-RPT-FINAL-ICH3-US-05-155867 EM-05-012107 Study to Determine the Ability of the Carbon Black Retention Method to Assess the Durability of Film-Forming Agents, Sponsor Final report (2010). ³ Cameron J, Hoffman D, Wilson J, Cherry G. “Comparison of two peri-wound skin protectants in venous leg ulcers: a randomized controlled trial”. J Wound Care, vol. 14, no. 5, 2005, pp. 233-236. ⁴ Rueda Lopez J, et.al. “A comparative study of a barrier product versus zinc oxide for the treatment of incontinent lesions”. Oral presentation at the World Union Wound Healing Society (WUWHS) Meeting in Paris; 2004. ⁵ CLIN-RPT-FINAL-INV-US-05-289804 EM-05-013869 Study to Assess the Durability of Film-Forming Barriers Using the Activated Carbon Retention Method (2016). ⁶ CLIN-SUPPORT-05-863013 NSBF Clinical Evidence Summary Brochure (2022). ⁷ 3M Data on file. ⁸ CLIN-SUPPORT-05-863013 NSBF Clinical Evidence Summary Brochure (2022). ⁹ CLIN-MISC-US-05-333303 Additional Clinical Evidence for NSBF (2017). ¹⁰ CLIN-MISC-US-05-169008 NSBF Friction Study Grove (2011)